Why it is moving
A new legislative proposal in the U.S. is targeting the pharmaceutical supply chain, aiming to reduce China's role.
Driver data is partial
Some drivers have no confirmed source evidence yet, read those as context, not confirmation.
Main drivers
U.S. Senate bill to reduce pharmaceutical dependence on China.
No confirmed source evidence yet.
Upcoming events